Skip to main content
SpringerLink
Log in

Epidemiology, Pathogenesis, and Risk Factors

  • Chapter
  • First Online:
Invasive Fungal Rhinosinusitis

  • 997 Accesses

Abstract

Invasive fungal sinusitis has been reported from all over the world, but its incidence varies widely with higher frequency reported in Sudan [1], southwestern states of the USA, and India, which have a hot and dry climate. The incidence seems to be higher in India than elsewhere in the world [2]. The true incidence of mucormycosis is unknown and probably underestimated due to the difficulties in antemortem diagnosis and the low autopsy rates in patients who die in the setting of either leukemia or stem cell transplant [3]. However, there is a consensus that there has been an overall increase in the incidence of all types of fungal sinusitis [2, 4]. At M.D. Anderson Cancer Center, Texas, the number of reported cases increased from 8 per 100,000 admissions during 1989–1993 to 17 per 100,000 admissions during 1994–1998 [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Veress B, Malik OA, Tayeb AA, El Daoud S, El Mahgoub S, El Hassan AM. Further observations on the primary paranasal Aspergillus granuloma in Sudan. Am J Trop Med Hyg. 1973;22:765–72.

    PubMed  CAS  Google Scholar 

  2. Chakrabarti A, Sharma SC. Paranasal sinus mycoses. Indian J Chest Dis Allied Sci. 2000;42:293–304.

    PubMed  CAS  Google Scholar 

  3. Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15 year period (1989–2003). Haematologica. 2006;91(7):986–9.

    PubMed  Google Scholar 

  4. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston VI. Zygomycosis in the 1990s in a tertiary care cancer center. Clin Infect Dis. 2000;30:851–6.

    Article  PubMed  CAS  Google Scholar 

  5. Talmi YP, Goldschmeid-Reouven A, Bakon M, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg. 2002;127:22–31.

    Article  PubMed  Google Scholar 

  6. Funada H, Matsuda T. Pulmonary mucormycosis in a hematology ward. Intern Med. 1996;35:540–4.

    Article  PubMed  CAS  Google Scholar 

  7. Chakrabarti A, Sharma SC, Chander J. Epidemiology and pathogenesis of paranasal sinus mycoses. Otolaryngol Head Neck Surg. 1992;107:745–50.

    PubMed  CAS  Google Scholar 

  8. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10 Suppl 1:31–47.

    Article  PubMed  Google Scholar 

  9. Herbrecht R, Letscher-Bru V, Bowden RA, et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis. 2001;20:460–6.

    PubMed  CAS  Google Scholar 

  10. Mileshkin L, Slavin M, Seymour JF, McKenzie A. Successful treatment of rhinocerebral zygomycosis using liposomal nystatin. Leuk Lymphoma. 2001;42:1119–23.

    Article  PubMed  CAS  Google Scholar 

  11. Wueppenhorst N, Lee M-K, Rappold E, Kayser G, Beckervordersandforth J, de With K, Serr A. Rhino-orbitocerebral zygomycosis caused by Conidiobolus incongruous in an immunocompromised patient in Germany. J Clin Microbiol. 2010;48(11):4322–5. doi: 10.1128/JCM.01188-10. Epub 2010 Sep 22.

    Google Scholar 

  12. Hejny C, Kerrison JB, Newman NJ, Stone CM. Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia. Am J Ophthalmol. 2001;132:111–2.

    Article  PubMed  CAS  Google Scholar 

  13. Lehrer RI, Howard DH, et al. Mucormycosis. Ann Intern Med. 1980;9:93–108.

    Article  Google Scholar 

  14. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogenic bone transplant recipients. Clin Infect Dis. 2001;32:1319–24.

    Article  PubMed  CAS  Google Scholar 

  15. Kontoyiannis DP, Chamilos G, Lewis RE, et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high risk hematologic malignancies and recipients of allogenic hematopoietic stem cell transplantation. Cancer. 2007;110(6):1303–6.

    Article  PubMed  Google Scholar 

  16. Morduchowicz G, Shmueli D, Shapira Z, et al. Rhinocerebral mucormycosis in renal transplant recipients: report of three cases and review of literature. Rev Infect Dis. 1986;8:441–6.

    Article  PubMed  CAS  Google Scholar 

  17. Jimenez C, Lumbreras C, Paseiro G, et al. Treatment of mucor infection after liver or pancreas-kidney transplantation. Transplant Proc. 2002;34:82–3.

    Article  PubMed  CAS  Google Scholar 

  18. Trifilio SM, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007;39:425.

    Article  PubMed  CAS  Google Scholar 

  19. Ingram CW, Sennesh J, Cooper JN, Perfect JR. Disseminated zygomycosis. Report of four cases and review. Rev Infect Dis. 1989;11:741–54.

    Article  PubMed  CAS  Google Scholar 

  20. Espinel-Ingroff A, Oakley LA, Kerkering TM. Opportunistic zygomycotic infections. Mycopathologica. 1987;97:33–41.

    Article  CAS  Google Scholar 

  21. Boelaert JR, Fenves AZ, Coburn JW. Mucormycosis among patients on dialysis. N Engl J Med. 1989;321:190–1.

    PubMed  CAS  Google Scholar 

  22. Daly AL, Velazquez LA, Bradley SF, Kauffman CA. Mucormycosis: association with deferoxamine therapy. Am J Med. 1989;87:468–71.

    Article  PubMed  CAS  Google Scholar 

  23. Toma A, Fenaux P, Dreyfus F, Cordonnier C. Infections in myelodysplastic syndromes. Haematologica. 2012;97(10):1459–70.

    Article  PubMed  CAS  Google Scholar 

  24. Lounis N, Truffot-Pernot C, Grosset J, Gordeuk VR, Boelaert JR. Iron and mycobacterium tuberculosis infection. J Clin Virol. 2001;20(3):123–6.

    Article  PubMed  CAS  Google Scholar 

  25. Schaible UE, Kauffman SH. Iron and microbial infection. Nat Rev Microbiol. 2004;2(12):946–53.

    Article  PubMed  CAS  Google Scholar 

  26. Boelaert JR, Locht M, Van Cutsem J, et al. Mucormycosis during deferoxamine therapy is a siderophore mediated infection. In vitro and in vivo animal studies. J Clin Invest. 1993;91:1979–86.

    Article  PubMed  CAS  Google Scholar 

  27. Abe F, Inaba H, Katoh T, Hotchi M. Effects of iron and deferoxamine on Rhizopus infection. Mycopathologica. 1990;110:87–90.

    Article  CAS  Google Scholar 

  28. Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol. 2006;55(3):251–8.

    Article  PubMed  CAS  Google Scholar 

  29. Boelaert JR Vandecasteele SJ, Appelberg R, Gordeuk VR. The effect of the host’s iron status on tuberculosis. J Infect Dis. 2007;195(12):1745–53.

    Article  Google Scholar 

  30. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Mycopathologica. 1990;110:87–90.

    Article  Google Scholar 

  31. Mowat AG, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971;284:621–7.

    Article  PubMed  CAS  Google Scholar 

  32. Garcia-Covarrubias L, Bartlett R, Bartlett DM, Wasserman RJ. Rhino-orbito-cerebral mucormycosis attributed to Apophysomyces elegans in an immunocompetent individual: a case report and review of literature. J Trauma. 2001;50:353–7.

    Article  PubMed  CAS  Google Scholar 

  33. Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs. 2004;64(18):1997–2020.

    Article  PubMed  CAS  Google Scholar 

  34. Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazole associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin Microbiol Infect. 2009;15(50):93–7.

    Article  PubMed  CAS  Google Scholar 

  35. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary care cancer center in the era of Aspergillus active anti fungal therapy: a case controlled observational study of 27 recent cases. J Infect Dis. 2005;191(8):1350–60.

    Article  PubMed  Google Scholar 

  36. Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood. 2011;118(5):1216–24.

    Article  PubMed  CAS  Google Scholar 

  37. Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation and management. Clin Microbiol Rev. 2005;18(3):556–69.

    Article  PubMed  CAS  Google Scholar 

  38. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.

    Article  PubMed  Google Scholar 

  39. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: an update on pathogenesis, clinical manifestations and management. Infect Dis Clin North Am. 2006;20(3):581–607.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ENT, PD Hinduja Hospital, Mahim, Mumbai, Maharashtra, 400 016, India

    Gauri Mankekar MS, DNB, PhD

Authors
  1. Gauri Mankekar MS, DNB, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gauri Mankekar MS, DNB, PhD .

Editor information

Editors and Affiliations

  1. ENT, PD Hinduja Hospital, Mumbai, Maharashtra, India

    Gauri Mankekar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer India

About this chapter

Cite this chapter

Mankekar, G. (2014). Epidemiology, Pathogenesis, and Risk Factors. In: Mankekar, G. (eds) Invasive Fungal Rhinosinusitis. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1530-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1530-1_3

  • Published:

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1529-5

  • Online ISBN: 978-81-322-1530-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation